Identification of potential biomarkers in Barrett’s esophagus derived esophageal adenocarcinoma

Almost 50% of esophageal adenocarcinoma (EAC) patients progressed from Barrett’s esophagus (BE). EAC is often diagnosed at late stages and is related to dismal prognosis. However, there are still no effective methods for stratification and therapy in BE and EAC. Two public datasets (GSE26886 and GSE...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Nan, Zhao, Hailiang, He, Juan, Xie, Xike, Liang, Liexin, Zuo, Guowen, Xiong, Mingyue, Liang, Yunxiao, Yi, Tingzhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910260/
https://www.ncbi.nlm.nih.gov/pubmed/36759514
http://dx.doi.org/10.1038/s41598-022-17107-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910260/
https://www.ncbi.nlm.nih.gov/pubmed/36759514
http://dx.doi.org/10.1038/s41598-022-17107-0

Ejemplares similares